Table 1 Clinicopathologic characteristics of patients and PGRP-S expression in HCC.
From: PGRP-S promotes hepatocellular carcinoma progression via MAPK/ERK pathway by interaction with TTC1
Characteristics | The expression of PGRP-S | χ2 value | P value | |
|---|---|---|---|---|
High | Low | |||
Gender | ||||
 Male | 32 | 3 | 3.252 | 0.0714 |
 Female | 7 | 3 | ||
Age (y) | ||||
  < 45 | 6 | 1 | 0.1732 | 0.6773 |
  ≥ 45 | 35 | 3 | ||
Differentiation | ||||
 High | 29 | 0 | 7.059 | 0.0293 |
 Moderate | 9 | 2 | ||
 Low | 3 | 2 | ||
Lymph metastasis | ||||
 Yes | 21 | 0 | 4.912 | 0.0267 |
 No | 15 | 4 | ||
